Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging … Read more
Sichuan Hebang Biotechnology Co Ltd (603077) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Sichuan Hebang Biotechnology Co Ltd (603077) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥165.40 Million) by net assets (CN¥18.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sichuan Hebang Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sichuan Hebang Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sichuan Hebang Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Outfront Media Inc. (REIT)
F:76C
|
0.159x |
|
Nexi S.p.A
PINK:NEXPF
|
0.057x |
|
Prestige Estates Projects Limited
NSE:PRESTIGE
|
0.113x |
|
Peyto Exploration&Development Corp
PINK:PEYUF
|
0.081x |
|
ABM Industries Incorporated
NYSE:ABM
|
0.075x |
|
SICC Co. Ltd.
SHG:688234
|
-0.030x |
|
ZENKOKU HOSHO CO. LTD.
F:ZKH
|
N/A |
|
TOMY Company, Ltd.
OTCGREY:TOMYF
|
N/A |
Annual Cash Flow Conversion Efficiency for Sichuan Hebang Biotechnology Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥19.01 Billion | CN¥467.93 Million | 0.025x | +147.94% |
| 2023-12-31 | CN¥20.22 Billion | CN¥200.76 Million | 0.010x | -92.58% |
| 2022-12-31 | CN¥19.76 Billion | CN¥2.64 Billion | 0.134x | -38.74% |
| 2021-12-31 | CN¥14.64 Billion | CN¥3.20 Billion | 0.218x | +569.51% |
| 2020-12-31 | CN¥11.31 Billion | CN¥368.85 Million | 0.033x | +129.32% |
| 2019-12-31 | CN¥11.45 Billion | CN¥162.92 Million | 0.014x | -83.13% |
| 2018-12-31 | CN¥11.20 Billion | CN¥944.39 Million | 0.084x | +437.35% |
| 2017-12-31 | CN¥11.27 Billion | CN¥176.94 Million | 0.016x | -70.60% |
| 2016-12-31 | CN¥10.78 Billion | CN¥575.26 Million | 0.053x | -21.77% |
| 2015-12-31 | CN¥6.58 Billion | CN¥449.20 Million | 0.068x | +58.44% |
| 2014-12-31 | CN¥4.75 Billion | CN¥204.67 Million | 0.043x | +134.78% |
| 2013-12-31 | CN¥3.29 Billion | CN¥-407.48 Million | -0.124x | -412.44% |
| 2012-12-31 | CN¥3.40 Billion | CN¥134.96 Million | 0.040x | -90.38% |
| 2011-12-31 | CN¥1.34 Billion | CN¥552.56 Million | 0.412x | +21.42% |
| 2010-12-31 | CN¥974.62 Million | CN¥330.77 Million | 0.339x | +262.97% |
| 2009-12-31 | CN¥737.62 Million | CN¥68.97 Million | 0.094x | -- |